Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prohibitin overexpression improves myocardial function in diabetic cardiomyopathy

25 Nov 2015

Abstract excerpt

// Wen-qian Dong 1 , Min Chao 5 , Qing-hua Lu 2 , Wei-li Chai 4 , Wei Zhang 1 , Xue-ying Chen 1 , Er-shun Liang 1 , Ling-bo Wang 1 , Hong-liang Tian 1 , Yu-guo Chen 1,3 and Ming-xiang Zhang 1 1 The Key Laboratory of Cardiovascular Remodeling and Function Research, Chinese Ministry of Education and Chinese Ministry of Public Health, Qilu Hospital, Shandong University, Jinan, China 2 Department of Cardiology, The...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cardiac Fibrosis and Remodeling
Share to Cardiomyopathy and Myosin Studies
Share to Cardiovascular Function and Risk Factors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 26623724
DOI: 10.18632/oncotarget.6384

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prohibitin overexpression improves myocardial function in diabetic cardiomyopathyPMID 26623724Read ↗

Caveolin 1 Reduces High Glucose-Induced Hypertrophy and Inflammatory Fibrosis of H9C2 Cardiomyocytes By Inhibiting NF-κB SignalingSemantic proximity Read ↗

Analysis of differentially expressed genes related to the development of diabetic cardiomyopathy in the myocardium of type-2 diabetic ratsSemantic proximity Read ↗

Novel Insights Into the Pathogenesis of Diabetic Cardiomyopathy and Pharmacological StrategiesSemantic proximity Read ↗

Role of microRNAs in the pathogenesis of diabetic cardiomyopathySemantic proximity Read ↗

Gastrodin attenuates diabetic cardiomyopathy characterised by myocardial fibrosis by inhibiting the KLK8-PAR1 signalling axisSemantic proximity Read ↗

Molecular Dysfunction and Phenotypic Derangement in Diabetic CardiomyopathySemantic proximity Read ↗

Circular RNA-OGDH promotes PANoptosis in diabetic cardiomyopathy: A novel mechanistic insightSemantic proximity Read ↗

Diabetic cardiomyopathy: The role of microRNAs and long non-coding RNAsSemantic proximity Read ↗

GDF11 alleviates pathological myocardial remodeling in diabetic cardiomyopathy through SIRT1-dependent regulation of oxidative stress and apoptosisSemantic proximity Read ↗

Forkhead box transcription factor 1: role in the pathogenesis of diabetic cardiomyopathySemantic proximity Read ↗

Current Status and Potential Therapeutic Strategies for Using Non-coding RNA to Treat Diabetic CardiomyopathySemantic proximity Read ↗

LncRNA TINCR is downregulated in diabetic cardiomyopathy and relates to cardiomyocyte apoptosisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.